GlucoTrack, Inc. (GCTK)
NASDAQ: GCTK · Real-Time Price · USD
0.2960
-0.0079 (-2.60%)
Jul 28, 2026, 1:32 PM EDT - Market open

GlucoTrack Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Selling, General & Admin
4.866.285.052.42.472.23
Research & Development
10.079.819.54.71.971.81
Total Operating Expenses
14.9416.0914.557.14.434.04
Operating Income
-14.94-16.09-14.55-7.1-4.43-4.04
Interest Income
0.090.060.58--0.01-0.03
Interest Expense
---0.01--
Other Non-Operating Income (Expense)
0.22-3.29-7.5-0.010.05
Total Non-Operating Income (Expense)
0.31-3.24-6.910.0100.03
Pretax Income
-14.62-19.33-21.46-7.1-4.43-4.01
Net Income
-14.62-19.33-21.46-7.1-4.43-4.01
Net Income to Common
-16.89-19.39-22.6-7.1-4.44-4.07
Net Income Growth
------
Shares Outstanding (Basic)
11----
Shares Outstanding (Diluted)
11----
Shares Change
131.28%-----
EPS (Basic)
-68.94-31.22----
EPS (Diluted)
-68.94-31.22----
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-16.44-15.34-12.59-0.01-3.73-0
Free Cash Flow Growth
------
Free Cash Flow Per Share
-16.67-24.69----
EBITDA
-14.88-16.05-14.51-7.1-4.41-4.04
EBIT
-14.94-16.09-14.55-7.1-4.43-4.04
SEC Filings: 10-K · 10-Q